News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Correction: Medicare Activism Alert


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 Sorry - the link in the last news blast did not work so I am resending this article!

Please help with this.  We can not let Medicare set a precedent with imposing such severe restrictions.  If they get away with it now, it is only going to get worse for the next treatments in the pipeline – which will probably be much more expensive than Optune.


Posted on: 06/01/2019

Activism Alert: Big Medicare Problem!

Medicare has published a proposed rule on coverage for Optune for GBM and there is an open comment period now where we can voice our thoughts on it.

The good news:  They will now cover Optune

The bad news:  They placed severe restrictions so that probably over 75% of GBM patients won't be able to get it covered under Medicare and you might not be able to use your current doctors!

Go to https://virtualtrials.com/activism.cfm for details on the problem and how you can help!  Please spread word of this and ask all of your friends and family to send emails!

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740